Detection of hepatocellular carcinoma: Gadoxetic acid-enhanced 3-dimensional magnetic resonance imaging versus multi-detector row computed tomography

Journal of Computer Assisted Tomography

Volumn 33, Issue 6, 2009, Pages 844-850

  Kim, Young Kon ^a   Kim, Chong Soo ^a   Han, Young Min ^a   Kwak, Hyo Sung ^a   Jin, Gong Yong ^a   Hwang, Seung Bae ^a   Chung, Gyung Ho ^a   Lee, Sang Yong ^a   Yu, Hee Chul ^a  

^a Jeonbuk National University Medical School and Hospital   (South Korea)

Author keywords

Computed tomography (CT); Contrast media; Liver neoplasms; Magnetic resonance (MR); Technology

Indexed keywords

COMPUTERIZED TOMOGRAPHY; DIAGNOSIS; MAGNETIC RESONANCE IMAGING; MAGNETISM; RESONANCE;

3-DIMENSIONAL; COMPUTED TOMOGRAPHY; CONTRAST MEDIUM; DIAGNOSTIC ACCURACY; HEPATOCELLULAR CARCINOMA; HEPATOCYTES; LIVER NEOPLASMS; MAGNETIC RESONANCE; MULTIDETECTOR ROW COMPUTED TOMOGRAPHY; TECHNOLOGY;

CONTRAST MEDIA;

GADOXETIC ACID; IOPROMIDE; CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADOLINIUM ETHOXYBENZYL DTPA; GADOLINIUM PENTETATE;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER DIAGNOSIS; CONE BEAM COMPUTED TOMOGRAPHY; CONSENSUS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FEMALE; HUMAN; IMAGE ENHANCEMENT; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY ANALYSIS; THREE DIMENSIONAL IMAGING; VASCULARIZATION; COMPUTER ASSISTED DIAGNOSIS; COMPUTER ASSISTED TOMOGRAPHY; LIVER TUMOR; METHODOLOGY; MIDDLE AGED; RADIOGRAPHY; REPRODUCIBILITY; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 73949155158     PISSN: 03638715     EISSN: None     Source Type: Journal    
DOI: 10.1097/RCT.0b013e3181a7e3c7     Document Type: Article

References (29)

1. Kim T, Murakami T, Oi H, et al. Detection of hypervascular hepatocellular carcinoma by dynamic MRI and dynamic spiral CT. J Comput Assist Tomogr. 1995;19:948-954.
2. Van Leeuwen MS, Noordzij J, Feldberg MA, et al. Focal liver lesions: characterization with triphasic spiral CT. Radiology. 1996;201: 327-336.
3. Kwak HS, Lee JM, Kim CS. Preoperative detection of hepatocellular carcinoma: comparison of combined contrast-enhanced MR imaging and combined CT during arterial portography and CT hepatic arteriography. Eur Radiol. 2004;14:447-457.
4. Hamm B, Thoeni RF, Gould RG, et al. Focal liver lesions: characterization with nonenhanced and dynamic contrast-material-enhanced MR imaging. Radiology. 1994;190: 417-423. (Pubitemid 24044245)
5. Jeong YY, Mitchell DG, Kamishima T. Small (<20 mm) enhancing hepatic nodules seen on arterial phase MR imaging of the cirrhotic liver: clinical implications. AJR Am J Roentgenol. 2002;178:1327-1334.
6. Kanematsu M, Kondo H, Semelka RC, et al. Early-enhancing non-neoplastic lesions on gadolinium-enhanced MRI of the liver. Clin Radiol. 2003;58:778-786.
7. Shimizu A, Ito K, Koike S, et al. Hepatic enhancement in multiphasic contrast-enhanced MDCT: comparison of high- and low-iodine-concentration contrast medium in same patients with chronic liver disease. AJR Am J Roentgenol. 2004;183:157-162.
8. Holland AE, Hecht EM, Hahn WY, et al. Importance of small (G or = 20-mm) enhancing lesions seen only during the hepatic arterial phase at MR imaging of the cirrhotic liver: evaluation and comparison with whole explanted liver. Radiology. 2005;237:938-944.
9. Kim YK, Lee YH, Kim CS, et al. Added diagnostic value of T2-weighted MR imaging to gadolinium-enhanced three-dimensional dynamic MR imaging for the detection of small hepatocellular carcinomas. Eur J Radiol. 2008;67:304-310.
10. Halavaara J, Breuer J, Ayuso C, et al. Liver tumor characterization: comparison between liver-specific gadoxetic acid disodium-enhanced MRI and biphasic CTVa multicenter trial. J Comput Assist Tomogr. 2006;30:345-354.
11. Huppertz A, Haraida S, Kraus A, et al. Enhancement of focal liver lesions at gadoxetic acidYenhanced MR imaging: correlation with histopathologic findings and spiral CTVinitial observations. Radiology. 2005;234:468-478.
12. Huppertz A, Balzer T, Blakeborough A, et al. Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acidYenhanced MR images with intraoperative findings. Radiology. 2004;230:266-275.
13. Kim YK, Lee YH, Kwak HS, et al. Detection of liver metastases: gadoxetic acidYenhanced three-dimensional MR imaging versus ferucarbotran-enhanced MR imaging. Eur J Radiol. 2009. In press.
14. Pugh RN, Murray-Lyon IM, Dawson JL, et al. Transection of the esophagus for bleeding esophageal varices. Br J Surg. 1973;60: 646-649.
15. Edmondson HA, Steiner PE. Primary carcinoma of liver: study of 100 cases among 48,900 necropsies. Cancer. 1954;7:462-503.
16. Kim YK, Kwak HS, Han YM, et al. Usefulness of combining sequentially acquired gadobenate dimeglumineYenhanced magnetic resonance imaging and resovist-enhanced magnetic resonance imaging for the detection of hepatocellular carcinoma: comparison with computed tomography hepatic arteriography and computed tomography arterioportography using 16-slice multidetector computed tomography. J Comput Assist Tomogr. 2007;31:702-711.
17. Lencioni R, Pinto F, Armillotta N, et al. Intrahepatic metastatic nodules of hepatocellular carcinoma detected at Lipiodol CT: imaging-pathologic correlation. Abdom Imaging. 1997;22:253-258.
18. Kim MJ, Choi JY, Lim JS, et al. Optimal scan window for detection of hypervascular hepatocellular carcinomas during MDCT examination. AJR Am J Roentgenol. 2006;187:198-206.
19. Grazioli L, Ollivetti L, Fugazzola C, et al. The pseudo-capsule in hepatocellular carcinoma: correlation between dynamic MR imaging and pathology. Eur Radiol. 1999;9:62-67.
20. Chakraborty DP, Winter LH. Free-response methodology: alternate analysis and a new observer-performance experiment. Radiology. 1990;74:873-881.
21. Metz CE. ROC methodology in radiologic imaging. Invest Radiol. 1986;21:720-733.
22. Rao JN, Scott AJ. A simple method for the analysis of clustered binary data. Biometrics. 1992;48:577-585.
23. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159-174.
24. Lee KH, Choi BI, Han JK, et al. Nodular hepatocellular carcinoma: variation of tumor conspicuity on single-level dynamic scan and optimization of fixed delay times for two-phase helical CT. J Comput Assist Tomogr. 2000;24:212-218.
25. Francis IR, Cohan RH, McNulty NJ, et al. Multidetector CT of the liver and hepatic neoplasms: effect of multiphasic imaging on tumor conspicuity and vascular enhancement. AJR Am J Roentgenol. 2003;180:1217-1224.
26. Schuhmann-Giampieri G, Schmitt-Willich H, Press WR, et al. Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system. Radiology. 1992;183:59-64.
27. Kim YK, Kim CS, Chung GH, et al. Comparison of gadobenate dimeglumine-enhanced dynamic MRI and 16-MDCT for the detection of hepatocellular carcinoma. AJR Am J Roentgenol. 2006;186:149-157.
28. Noguchi Y, Murakami T, Kim T, et al. Detection of hypervascular hepatocellular carcinoma by dynamic magnetic resonance imaging with double-echo chemical shift in-phase and opposed-phase gradient echo technique: comparison with dynamic helical computed tomography imaging with double arterial phase. J Comput Assist Tomogr. 2002;26:981-987.
29. Kim SJ, Kim SH, Lee J, et al. Ferucarbotran-enhanced 3.0-T magnetic resonance imaging using parallel imaging technique compared with triple-phase multidetector row computed tomography for the preoperative detection of hepatocellular carcinoma. J Comput Assist Tomogr. 2008;32:379-385.